Müller, B. et al. 2024. Severe cutaneous toxicity in a 67-year-old patient with metastatic urothelial carcinoma undergoing therapy with enfortumab vedotin and pembrolizumab. European Journal of Case Reports in Internal Medicine. 11, 12 (Nov. 2024). DOI:https://doi.org/10.12890/2024_005003.